Zomedica Appoints New CFO to Drive Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 19 2024
0mins
Should l Buy ?
Source: Business Insider
Zomedica Pharmaceuticals Update: Zomedica has appointed Scott A. Jordan as Executive Vice President, Finance and Chief Financial Officer, effective January 1, 2025, bringing over 30 years of experience in life sciences and diagnostics to the role.
Impact on Growth: Jordan's expertise in strategic finance and business development is anticipated to enhance Zomedica's growth within the animal health sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
